CDSCO

These medicines are prescribed to treat conditions like chest infections such as pneumonia, metabolic disorder, high blood sugar etc.

As part of the continuous regulatory surveillance, drug samples are picked from sales/distribution point, analyzed and list of Not of…

India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI

In its August 2024 report, the CDSCO identified over 50 drugs as Not of Standard Quality (NSQ), including popular medicines…

In a press conference, conducted earlier this month, the company claimed that the DCGI has given final approval to the…

According to GLOBOCAN 2022 data, lung cancer remains the fourth most common cause of cancer-related mortality in India.

On September 3, the pharmaceutical company conducted a press conference to announced that it has received final approval from the…

According to the circular, the waiver has been granted under Rule 101 of the New Drugs and Clinical Trials Rules,…

This formulation is indicated for the treatment of complicated Urinary Tract Infections (cUTI) including acute Pyelonephritis, Hospital-Acquired Pneumonia (HAP) including…

According to the list, some of the major companies whose samples have been flagged include Glenmark Pharmaceuticals, Micro Labs, Sun…

According to the drug regulator, dissolution, disintegration and assay are some of the reason of drug test failure.